Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.
暂无分享，去创建一个
H. Dombret | A. Krämer | N. Russell | G. Martinelli | J. Cortes | M. Levis | Ken Kobayashi | A. Yver | A. Y. Leung | Nanxiang Ge | A. Perl | D. Hogge | S. Sica | P. Montesinos | S. Khaled | M. Radsak | S. Ganguly | B. Jonas | M. Arunachalam | Yufen Zhang | P. Mehta | R. Namuyinga | M. Holmes